Nitric oxide gas delivers targeted vasodilation in treatments for pulmonary hypertension and acute respiratory distress. Neonatal intensive care units, cardiology departments, and surgical suites in hospitals obtain it from pharmaceutical gas manufacturers for precise therapeutic administration.